The Effect of Seoritae Extract in Men with Mild to Moderate Lower Urinary Tract Symptoms Suggestive of Benign Prostatic Hyperplasia

We evaluated the effects of Seoritae extract (SE) on mild to moderate lower urinary tract symptoms (LUTS) suggestive of benign prostatic hyperplasia (BPH). Seventy-six subjects with mild to moderate LUTS suggestive of BPH were prospectively recruited from the urology outpatient clinic and assigned to either SE (4200 mg or 6 tablets 3 times a day) or matching placebo. The primary outcome variable, the International Prostatic Symptom Score (IPSS), was evaluated at baseline and at 4 and 12 weeks. Postvoid residual volume (PVR), maximum urine flow rate (Q max), and prostate-specific antigen (PSA) levels were evaluated. IPSSs decreased significantly from baseline to 12 weeks within the SE group. Significant improvements in IPSS voiding scores at 4 and 12 weeks were also observed in the SE group compared to the placebo group. IPSS storage and quality of life scores were also significantly decreased at 12 weeks in the SE group. There was no change in Q max or PVR in both groups after 12 weeks. Administration of SE for 12 weeks led to significant improvements in LUTS, and it can be concerned as a reasonable and safe alternative for men with mild to moderate LUTS.

[1]  B. Yoon,et al.  AB069. The effect of Seoritae extract in men with mild-to-moderate lower urinary tract symptoms suggestive of benign prostatic hyperplasia , 2016, Translational Andrology and Urology.

[2]  A. Vitalone,et al.  What do we know about phytotherapy of benign prostatic hyperplasia? , 2015, Life sciences.

[3]  S. Gangemi,et al.  Oxidative Stress in Benign Prostatic Hyperplasia: A Systematic Review , 2014, Urologia Internationalis.

[4]  R. Capasso,et al.  Phytotherapy of Benign Prostatic Hyperplasia. A Minireview , 2014, Phytotherapy research : PTR.

[5]  C. Han,et al.  Seoritae Extract Reduces Prostate Weight and Suppresses Prostate Cell Proliferation in a Rat Model of Benign Prostate Hyperplasia , 2014, Evidence-based complementary and alternative medicine : eCAM.

[6]  E. Ogwuche,et al.  The relationship between prostate volume and international prostate symptom score in Africans with benign prostatic hyperplasia. , 2012, Nigerian journal of medicine : journal of the National Association of Resident Doctors of Nigeria.

[7]  S. Kim,et al.  Effects of anthocyanin extracted from black soybean seed coat on spermatogenesis in a rat varicocele-induced model. , 2012, Reproduction, fertility, and development.

[8]  T. Mansoor,et al.  Evaluation of Oxidative Stress and DNA Damage in Benign Prostatic Hyperplasia Patients and Comparison with Controls , 2012, Indian Journal of Clinical Biochemistry.

[9]  E. Hui,et al.  Isoflavones in treating watchful waiting benign prostate hyperplasia: a double-blinded, randomized controlled trial. , 2012, Journal of alternative and complementary medicine.

[10]  U. Ha,et al.  Anthocyanin extracted from black soybean reduces prostate weight and promotes apoptosis in the prostatic hyperplasia-induced rat model. , 2010, Journal of agricultural and food chemistry.

[11]  孙霄茜,et al.  Evidence-based Complementary and Alternative Medicine简介 , 2009 .

[12]  L. Hill,et al.  Rapid efficacy of the highly selective α(1A)-adrenoceptor antagonist silodosin in men with signs and symptoms of benign prostatic hyperplasia: pooled results of 2 phase 3 studies. , 2009, The Journal of urology.

[13]  P. Gontero*,et al.  Finasteride 5 mg and sexual side effects: how many of these are related to a nocebo phenomenon? , 2007, The journal of sexual medicine.

[14]  S. Nordeen,et al.  Prostatic fluid concentrations of isoflavonoids in soy consumers are sufficient to inhibit growth of benign and malignant prostatic epithelial cells in vitro , 2006, The Prostate.

[15]  P. Elder,et al.  Circulating levels of isoflavones and markers of 5α-reductase activity are higher in Japanese compared with New Zealand males: What is the role of circulating steroids in prostate disease? , 2005, Steroids.

[16]  F. Greenway,et al.  Black raspberry extract and fractions contain angiogenesis inhibitors. , 2005, Journal of agricultural and food chemistry.

[17]  J. Potter,et al.  Soy isoflavones do not modulate prostate-specific antigen concentrations in older men in a randomized controlled trial. , 2004, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

[18]  Y. Asiri.  The ABC Clinical Guide to Herbs , 2004, Annals of Saudi Medicine.

[19]  E. Simpson,et al.  Anti‐androgenic action by red clover‐derived dietary isoflavones reduces non‐malignant prostate enlargement in aromatase knockout (arko) mice , 2003, The Prostate.

[20]  A. Cassidy.  Potential risks and benefits of phytoestrogen-rich diets. , 2003, International journal for vitamin and nutrition research. Internationale Zeitschrift fur Vitamin- und Ernahrungsforschung. Journal international de vitaminologie et de nutrition.

[21]  R. Liu,et al.  Antioxidant and antiproliferative activities of raspberries. , 2002, Journal of agricultural and food chemistry.

[22]  K. Dreikorn.  The role of phytotherapy in treating lower urinary tract symptoms and benign prostatic hyperplasia , 2002, World Journal of Urology.

[23]  B. Chung,et al.  Comparative study of concentration of isoflavones and lignans in plasma and prostatic tissues of normal control and benign prostatic hyperplasia. , 2002, Yonsei medical journal.

[24]  G. Gerber,et al.  Randomized, double-blind, placebo-controlled trial of saw palmetto in men with lower urinary tract symptoms. , 2001, Urology.

[25]  T. Wilt,et al.  Phytotherapy for benign prostatic hyperplasia , 2000, Public Health Nutrition.

[26]  T. Kirkwood,et al.  Accumulation of defective mitochondria through delayed degradation of damaged organelles and its possible role in the ageing of post-mitotic and dividing cells. , 2000, Journal of theoretical biology.

[27]  G N Collins,et al.  Correlation between prostate size estimated by digital rectal examination and measured by transrectal ultrasound. , 1997, Urology.

[28]  K. Griffiths,et al.  Inhibition of 5 alpha-reductase in genital skin fibroblasts and prostate tissue by dietary lignans and isoflavonoids. , 1995, The Journal of endocrinology.

[29]  N. Bissada,et al.  Accuracy of preoperative estimation of resection weight in transurethral prostatectomy. , 1976, The Journal of urology.

[30]  Dean Hamer,et al.  ETIOLOGY , 1931 .

[31]  W. Marsden.  I and J , 2012 .

[32]  Ji-Hong Liu,et al.  [Red clover isoflavones inhibit the proliferation and promote the apoptosis of benign prostatic hyperplasia stromal cells]. , 2010, Zhonghua nan ke xue = National journal of andrology.

[33]  S. Dutkiewics.  Efficacy and tolerability of drugs for treatment of benign prostatic hyperplasia , 2004, International Urology and Nephrology.

[34]  T. Wilt,et al.  Serenoa repens for benign prostatic hyperplasia. , 2000, The Cochrane database of systematic reviews.

[35]  F. Bracher.  Phytotherapie der benignen Prostatahyperplasie , 1997, Der Urologe A.

[36]  P. Walsh,et al.  Clinical and experimental studies of benign prostatic hyperplasia. , 1990, The Urologic clinics of North America.